Safety Incidents OSHA Severe Injury Reports · 2015–2025
5,189,645Inspections Most recent open 2026-07-16 Last loaded 2026-07-20

OSHA Inspection: KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.

Planned inspection · Health discipline

On , OSHA opened a planned health inspection of KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC. in 4000 CENTREGREEN WAY, SUITE 300, CARY, NC 27513 (NAICS 541710). OSHA activity number 306590092.

Watch King Pharmaceuticals Research & Development, INC. — free Get an email when a new federal OSHA severe-injury report for King Pharmaceuticals Research & Development, INC. is published. One employer, no account, unsubscribe in one click.
Site address
4000 CENTREGREEN WAY, SUITE 300
City
CARY
State
NC
ZIP
27513
Inspection type
Planned (H)
Scope
Complete (A)
Discipline
Health
Advance notice
No
Union status
N
Opened
Closing conference
Case closed
Data loaded
NAICS code
541710
SIC code (legacy)
8733
Employees
53
Ownership type
A
Industry flags
Manufacturing health.

3 citations on file for this inspection.

1910.38 A01

Other-than-serious 1 instance 53 exposed
Issued
Abate by

1910.1200 F01 I

Other-than-serious 1 instance 53 exposed
Issued
Abate by

1910.1200 F01 II

Other-than-serious 1 instance 53 exposed
Issued
Abate by

This record is reproduced from the U.S. Department of Labor Open Data API (OSHA inspection dataset). The original IMIS detail view is available at OSHA's Establishment Search for activity number 306590092.